GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AMED Co Ltd (ROCO:7575) » Definitions » Debt-to-EBITDA

AMED Co (ROCO:7575) Debt-to-EBITDA : 1.41 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is AMED Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

AMED Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$112.0 Mil. AMED Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$145.4 Mil. AMED Co's annualized EBITDA for the quarter that ended in Dec. 2023 was NT$182.1 Mil. AMED Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 1.41.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for AMED Co's Debt-to-EBITDA or its related term are showing as below:

ROCO:7575' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.64   Med: 2.85   Max: 3.97
Current: 1.64

During the past 5 years, the highest Debt-to-EBITDA Ratio of AMED Co was 3.97. The lowest was 1.64. And the median was 2.85.

ROCO:7575's Debt-to-EBITDA is ranked worse than
55.84% of 437 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs ROCO:7575: 1.64

AMED Co Debt-to-EBITDA Historical Data

The historical data trend for AMED Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AMED Co Debt-to-EBITDA Chart

AMED Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
3.97 3.04 2.85 2.01 1.64

AMED Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only 2.59 2.63 1.73 2.07 1.41

Competitive Comparison of AMED Co's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, AMED Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AMED Co's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AMED Co's Debt-to-EBITDA falls into.



AMED Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

AMED Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(111.975 + 145.416) / 157.326
=1.64

AMED Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(111.975 + 145.416) / 182.088
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


AMED Co  (ROCO:7575) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


AMED Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of AMED Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


AMED Co (ROCO:7575) Business Description

Traded in Other Exchanges
N/A
Address
No. 14, Wuquan 7th Road, 4th Floor, Wugu District, New Taipei, TWN
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.

AMED Co (ROCO:7575) Headlines

No Headlines